Intellipharmaceutics International Inc. (IPCI) Stock Price, Forecast & Analysis

NASDAQ:IPCI

0.2106
-0.06 (-22%)
At close: Mar 20, 2019
0.2151
+0 (+2.14%)
After Hours: 3/20/2019, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

IPCI Key Statistics, Chart & Performance

Key Statistics
Market Cap4.62M
Revenue(TTM)1.71M
Net Income(TTM)-13.75M
Shares21.93M
Float19.98M
52 Week High6.5
52 Week Low0.2
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-2.89
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
IPCI short term performance overview.The bars show the price performance of IPCI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

IPCI long term performance overview.The bars show the price performance of IPCI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of IPCI is 0.2106 null. In the past month the price decreased by -44.58%. In the past year, price decreased by -96.49%.

Intellipharmaceutics International Inc. / IPCI Daily stock chart

IPCI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
IPCI Full Technical Analysis Report

IPCI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IPCI. IPCI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IPCI Full Fundamental Analysis Report

IPCI Financial Highlights

Over the last trailing twelve months IPCI reported a non-GAAP Earnings per Share(EPS) of -2.89. The EPS increased by 0.34% compared to the year before.


Industry RankSector Rank
PM (TTM) -802.68%
ROA -119.81%
ROE -335.12%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-737.5%
Sales Q2Q%-64.03%
EPS 1Y (TTM)0.34%
Revenue 1Y (TTM)-68.89%
IPCI financials

IPCI Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y65.4%
Revenue Next YearN/A
IPCI Analyst EstimatesIPCI Analyst Ratings

IPCI Ownership

Ownership
Inst Owners11.05%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
IPCI Ownership

About IPCI

Company Profile

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.

Company Info

Intellipharmaceutics International Inc.

30 WORCESTER ROAD

TORONTO A6 M9W 5X2

CEO: Isa Odidi

Phone: 416-798-3001

Intellipharmaceutics International Inc. / IPCI FAQ

What does IPCI do?

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.


What is the stock price of Intellipharmaceutics International Inc. today?

The current stock price of IPCI is 0.2106 null. The price decreased by -22% in the last trading session.


Does IPCI stock pay dividends?

IPCI does not pay a dividend.


How is the ChartMill rating for Intellipharmaceutics International Inc.?

IPCI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the market cap for Intellipharmaceutics International Inc.?

Intellipharmaceutics International Inc. (IPCI) has a market capitalization of 4.62M null. This makes IPCI a Nano Cap stock.